Pharmacogenomics and Personalized Medicine
译名:药物基因组学与个性化医学
Pharmacogenomics & Personalized Medicine
1-3
2026
影响因子区间
—
平台估算
82%
2025
中国作者发文占比
3300 USD
收费
期刊简介:Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.In particular, emphasis will be given to: Genomic and proteomic profilingGenetics and drug metabolismTargeted drug identification and discoveryOptimizing drug selection & dosage based on patient's genetic profileDrug related morbidity & mortality interventionAdvanced disease screening and targeted therapeutic interventionGenetic based vaccine developmentPatient satisfaction and preferenceHealth economic evaluationsPractical and organizational issues in the development and implementation of personalized medicine programs.
【译文】《药理学基因组学与个性化医疗》是一本国际性的、同行评审的、开放获取的期刊,主要研究基因型对药理学的影响,从而推动个性化治疗计划和个体化药物选择的发展,以提高安全性、有效性和可持续性。特别强调以下内容:基因组学和蛋白质组学分析、遗传学和药物代谢、靶向药物鉴定和发现、基于患者遗传特征的药物选择和剂量优化、药物相关发病率和死亡率干预、高级疾病筛查和靶向治疗干预、基于遗传的疫苗开发、患者满意度和偏好、健康经济评估、个性化医疗项目开发和实施中的实际和组织问题。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |